• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性患者的焦虑和抑郁患病率:观察性研究数据的系统评价。

The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data.

机构信息

Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele, Staffordshire ST5 5BG, UK.

出版信息

BMC Ophthalmol. 2014 Jun 12;14:78. doi: 10.1186/1471-2415-14-78.

DOI:10.1186/1471-2415-14-78
PMID:24923726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4094542/
Abstract

BACKGROUND

Comorbid mental health problems have been shown to have an adverse effect on the quality of life of people with common eye disorders. This study aims to assess whether symptoms of anxiety and/or depression are more prevalent in people with age-related macular degeneration (AMD) than in people without this condition.

METHODS

A systematic search of electronic databases (Medline, CINAHL, EMBASE, PsycINFO) from inception to February 2012 was conducted to identify studies of AMD populations which measured symptoms of anxiety and/or depression. Reference checking of relevant articles was also performed. Data on the study setting, prevalence and how anxiety and depression were measured were extracted from the papers. Critical appraisal was performed using the Critical Appraisal Skills Programme (CASP) tools.

RESULTS

A total of 16 papers were included in the review, from an original search result of 597. The prevalence estimates, taken from nine cross-sectional and cohort studies, ranged from 15.7%-44% for depressive symptoms and 9.6%-30.1% for anxiety symptoms in people with AMD. The seven case-control studies found that people with AMD were more likely to experience symptoms of depression compared with those without AMD, but not more likely to experience symptoms of anxiety.

CONCLUSIONS

Overall, the evidence suggests that symptoms of depression are more prevalent amongst AMD populations than anxiety symptoms. The heterogeneity of the studies included in this review means that it is difficult to draw strong conclusions as to the true estimates of depression and anxiety symptoms in AMD populations and prevented formal meta-analysis. Further research which specifies clinical anxiety and gives clear definitions as to the type of AMD being investigated is required.

摘要

背景

合并的心理健康问题已被证明对患有常见眼部疾病的人的生活质量有不利影响。本研究旨在评估年龄相关性黄斑变性(AMD)患者的焦虑和/或抑郁症状是否比没有这种情况的患者更为普遍。

方法

对从开始到 2012 年 2 月的电子数据库(Medline、CINAHL、EMBASE、PsycINFO)进行了系统检索,以确定评估 AMD 人群中焦虑和/或抑郁症状的研究。还对相关文章进行了参考文献检查。从论文中提取了关于研究背景、患病率以及如何测量焦虑和抑郁的信息。使用关键评估技能计划(CASP)工具进行了关键评估。

结果

综述共纳入 16 篇论文,最初检索结果为 597 篇。从九项横断面和队列研究中得出的抑郁症状患病率估计值在 AMD 患者中为 15.7%-44%,焦虑症状为 9.6%-30.1%。七项病例对照研究发现,AMD 患者比没有 AMD 的患者更有可能出现抑郁症状,但不太可能出现焦虑症状。

结论

总体而言,有证据表明 AMD 人群中抑郁症状比焦虑症状更为普遍。本综述中纳入的研究存在异质性,因此很难就 AMD 人群中抑郁和焦虑症状的真实估计值得出强有力的结论,也无法进行正式的荟萃分析。需要进一步的研究来明确临床焦虑,并明确界定正在研究的 AMD 类型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4b/4094542/28016ecfddea/1471-2415-14-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4b/4094542/28016ecfddea/1471-2415-14-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4b/4094542/28016ecfddea/1471-2415-14-78-1.jpg

相似文献

1
The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data.年龄相关性黄斑变性患者的焦虑和抑郁患病率:观察性研究数据的系统评价。
BMC Ophthalmol. 2014 Jun 12;14:78. doi: 10.1186/1471-2415-14-78.
2
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
3
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
4
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
5
Parent-training programmes for improving maternal psychosocial health.改善孕产妇心理社会健康的家长培训项目。
Cochrane Database Syst Rev. 2004(1):CD002020. doi: 10.1002/14651858.CD002020.pub2.
6
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.抗血管内皮生长因子生物类似药治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD015804. doi: 10.1002/14651858.CD015804.pub2.
7
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
8
Music-based therapeutic interventions for people with dementia.针对痴呆症患者的基于音乐的治疗干预措施。
Cochrane Database Syst Rev. 2025 Mar 7;3(3):CD003477. doi: 10.1002/14651858.CD003477.pub5.
9
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
10
Communication skills training for mental health professionals working with people with severe mental illness.针对为重度精神疾病患者提供服务的心理健康专业人员的沟通技能培训。
Cochrane Database Syst Rev. 2017 Jun 13;6(6):CD010006. doi: 10.1002/14651858.CD010006.pub2.

引用本文的文献

1
Prioritising the Burden of Geographic Atrophy and Treatment Expectations: A Modified Nominal Group Technique Study with International Patient-Led Organisations.确定地理性萎缩的负担及治疗期望的优先级:一项与国际患者主导组织合作开展的改良名义组技术研究
Clin Ophthalmol. 2025 Sep 9;19:3317-3329. doi: 10.2147/OPTH.S525046. eCollection 2025.
2
Perceived stress levels among patients treated for neovascular age-related macular degeneration with anti-VEGF injections.接受抗血管内皮生长因子注射治疗的新生血管性年龄相关性黄斑变性患者的感知压力水平。
Graefes Arch Clin Exp Ophthalmol. 2025 Jun 28. doi: 10.1007/s00417-025-06883-w.
3
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study.

本文引用的文献

1
Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008.美国 2005-2008 年 NHANES 研究中 20 岁及以上人群抑郁与功能性视力丧失的关系
JAMA Ophthalmol. 2013 May;131(5):573-81. doi: 10.1001/jamaophthalmol.2013.2597.
2
Explaining the relationship between three eye diseases and depressive symptoms in older adults.阐述老年人三种眼部疾病与抑郁症状之间的关系。
Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2308-13. doi: 10.1167/iovs.11-9330.
3
5.7 Times more expensive than liquid gold.
创新型雷珠单抗与生物类似药雷珠单抗在脉络膜视网膜血管疾病中的比较安全性分析——CRsIBS研究
Clin Ophthalmol. 2025 Mar 28;19:1093-1102. doi: 10.2147/OPTH.S515479. eCollection 2025.
4
Protocol for a mixed-methods randomised controlled trial evaluating the psychosocial effects of an expressive arts-based intervention on adults with age-related macular degeneration.一项混合方法随机对照试验的方案,该试验评估基于表达性艺术的干预措施对患有年龄相关性黄斑变性的成年人的心理社会影响。
BMJ Open. 2024 Dec 20;14(12):e088311. doi: 10.1136/bmjopen-2024-088311.
5
Geographic atrophy and factors associated with disease progression among Medicare Advantage enrollees.医疗保险优势参保者中的地理性萎缩及与疾病进展相关的因素。
J Manag Care Spec Pharm. 2025 Jan;31(1):42-52. doi: 10.18553/jmcp.2025.31.1.42.
6
Pooled Multicenter Safety Analysis of Lupin's Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases.鲁宾公司的玻璃体内生物类似药雷珠单抗(Ranieyes)治疗脉络膜视网膜血管疾病的多中心安全性汇总分析
Ophthalmol Ther. 2025 Jan;14(1):129-139. doi: 10.1007/s40123-024-01065-z. Epub 2024 Nov 19.
7
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.保加利亚、德国和美国晚期年龄相关性黄斑变性的经济负担
JAMA Ophthalmol. 2024 Dec 1;142(12):1123-1130. doi: 10.1001/jamaophthalmol.2024.4401.
8
Were there any missing mediators between visual impairment and anxiety symptoms? Results from Chinese Longitudinal Healthy Longevity Survey.在视力障碍和焦虑症状之间是否存在缺失的中介因素?来自中国健康长寿纵向研究的结果。
Front Public Health. 2024 Oct 16;12:1448638. doi: 10.3389/fpubh.2024.1448638. eCollection 2024.
9
Emotional State Evaluation of Retinitis Pigmentosa Patients with the Beck Depression Inventory.用贝克抑郁自评量表评估色素性视网膜炎患者的情绪状态。
Turk J Ophthalmol. 2024 Aug 28;54(4):205-211. doi: 10.4274/tjo.galenos.2024.77489.
10
Multimodal Eye Imaging, Retina Characteristics, and Psychological Assessment Dataset.多模态眼成像、视网膜特征与心理评估数据集
Sci Data. 2024 Aug 2;11(1):836. doi: 10.1038/s41597-024-03690-6.
比液态黄金贵5.7倍。
Br J Ophthalmol. 2012 Jul;96(7):1046. doi: 10.1136/bjophthalmol-2011-301241. Epub 2011 Nov 28.
4
Depressive symptoms and quality of life in people with age- related macular degeneration.年龄相关性黄斑变性患者的抑郁症状和生活质量。
Ophthalmic Physiol Opt. 2011 Jul;31(4):375-80. doi: 10.1111/j.1475-1313.2011.00848.x. Epub 2011 May 24.
5
Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration.年龄相关性黄斑变性抗血管内皮生长因子治疗后仍出现抑郁症状
Arch Ophthalmol. 2010 Apr;128(4):506-8. doi: 10.1001/archophthalmol.2010.24.
6
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目:PRISMA声明。
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. doi: 10.7326/0003-4819-151-4-200908180-00135. Epub 2009 Jul 20.
7
Longitudinal incidence of adverse outcomes of age-related macular degeneration.年龄相关性黄斑变性不良结局的纵向发病率
Arch Ophthalmol. 2009 Mar;127(3):320-7. doi: 10.1001/archophthalmol.2008.613.
8
Burden of illness of bilateral neovascular age-related macular degeneration in Spain.西班牙双侧新生血管性年龄相关性黄斑变性的疾病负担
Curr Med Res Opin. 2008 Jul;24(7):2103-11. doi: 10.1185/03007990802214300. Epub 2008 Jun 10.
9
Prevalence of common mental disorders in general practice attendees across Europe.欧洲全科医疗就诊者中常见精神障碍的患病率。
Br J Psychiatry. 2008 May;192(5):362-7. doi: 10.1192/bjp.bp.107.039966.
10
Anxiety disorders and comorbid medical illness.焦虑症与共病性躯体疾病。
Gen Hosp Psychiatry. 2008 May-Jun;30(3):208-25. doi: 10.1016/j.genhosppsych.2007.12.006.